1. COVID-19 threatens M&A already in process— Physician survey shows widespread concern about access to testing and medical supplies for COVID— Novartis cancels $1B generics sale — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

FDA delays our Injectable!!!

Discussion in 'Braeburn Pharmaceuticals' started by anonymous, Jan 22, 2018 at 2:25 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Fake news, folks. Everything is gonna be just fine!
     

  2. anonymous

    anonymous Guest

    100%. Right? Rofl. Idiots
     
  3. anonymous

    anonymous Guest

    Any updates?
     
  4. anonymous

    anonymous Guest

    CAM product to be refiled in April, at least 6 months until approval if the FDA agrees
     
  5. anonymous

    anonymous Guest

    If’s mfer